Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Escalation Trial of Docetaxel Plus Irinotecan in Patients With Advanced Cancer

NCT00004923 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00004923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Escalation Trial of Docetaxel Plus Irinotecan in Patients With Advanced Cancer
Lead sponsor
Yale University
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 1999
Completion date
May 31, 2006
Enrollment
47 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific